Health Care · owned by 2 fund managers
Who owns Adma Biologics (ADMA)?
2 of the 22 fund managers we track hold Adma Biologics, worth $37M combined as of Q2 2026. Stanley Druckenmiller has the biggest bet at 0.4% of the portfolio.
Ownership summary
Fund manager owners
2 / 22
0 opened new positions
Combined value
$37M
At quarter-end prices
Biggest weight
0.4%
Stanley Druckenmiller
Buyers / sellers
1 / 0
Changes in Q2 2026
Smart money take
Why it matters
When several investors with very different styles own the same company, it’s often worth a closer look. Adma Biologics appears in 2 of our 22 portfolios.
- Largest holder: Stanley Druckenmiller (0.4% of portfolio)
- 1 manager bought or added this quarter
- 0 managers trimmed or sold out
This is not a recommendation. Do your own research.
Fund managers who own ADMA
SEC 13F · Q2 2026| Investor | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Stanley Druckenmiller Duquesne Family Office | 0.45% | Added | 2,784,110 | $23M |
| Terry Smith Fundsmith | 0.10% | Hold | 1,649,493 | $14M |
Coming soon · QWERTx Pro
Professionally managed portfolios, built around your life.
We are building QWERTx Pro: portfolios matched to your risk profile and time horizon, managed by experienced financial advisors. Join the waitlist to hear first when it launches.
